Trial Site Detail

 

Drug:	Navitoclax + Sorafenib
Trial:	Navitoclax and Sorafenib Tosylate in Treating Patients With Relapsed or Refractory Solid Tumors
Conditions:	Solid Neoplasm
Trial Status:	Suspended

 

Greenbaum Cancer Center, University of Maryland       Baltimore , MD 21201 USA

 

Principal Investigator:	Edward A. Sausville
Contact:	Edward A. Sausville 800-888-8823
Activation Status of this Site:	Closed
Notes about this Site:
Greenbaum Cancer Center, University of Maryland Website:

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.